ES483532A1 - Procedimiento para la obtencion de derivados de acido a-ami-nofenilacetico. - Google Patents

Procedimiento para la obtencion de derivados de acido a-ami-nofenilacetico.

Info

Publication number
ES483532A1
ES483532A1 ES483532A ES483532A ES483532A1 ES 483532 A1 ES483532 A1 ES 483532A1 ES 483532 A ES483532 A ES 483532A ES 483532 A ES483532 A ES 483532A ES 483532 A1 ES483532 A1 ES 483532A1
Authority
ES
Spain
Prior art keywords
carbon atoms
alkyl
acid derivatives
alpha
aminophenylacetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES483532A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES483532A1 publication Critical patent/ES483532A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Sustancias de la serie indol que poseen fuertes propiedades antiflogísticas y antipiréticas. Estos antiflogísticos conocidos tienen, sin embargo, la desventaja de presentar efectos secundarios indeseados o poseer solo una reducida actividad terapéutica y entonces se han de administrar en grandes cantidades. Los compuestos de la presente invención muestran, además de una fuerte actividad terapéutica solo unos efectos secundarios muy reducidos y representan.
ES483532A 1978-08-22 1979-08-21 Procedimiento para la obtencion de derivados de acido a-ami-nofenilacetico. Expired ES483532A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782836613 DE2836613A1 (de) 1978-08-22 1978-08-22 Alpha -aminophenylessigsaeurederivate

Publications (1)

Publication Number Publication Date
ES483532A1 true ES483532A1 (es) 1980-05-16

Family

ID=6047604

Family Applications (1)

Application Number Title Priority Date Filing Date
ES483532A Expired ES483532A1 (es) 1978-08-22 1979-08-21 Procedimiento para la obtencion de derivados de acido a-ami-nofenilacetico.

Country Status (9)

Country Link
EP (1) EP0011092B1 (es)
JP (1) JPS5533476A (es)
AT (1) ATE1240T1 (es)
DE (2) DE2836613A1 (es)
DK (1) DK349579A (es)
ES (1) ES483532A1 (es)
FI (1) FI792586A7 (es)
NO (1) NO792590L (es)
PT (1) PT70078A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134932A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Optisch reine (alpha)-aminophenylessigsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung fuer die herstellung von arzneimitteln
CA2120367C (en) * 1992-06-30 2004-05-11 Howard K. Shapiro Compositions and use of pharmaceutical compositions in the treatment of symptoms of disorders related to chronic inflammatory diseases and etiologically related symptomology
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
WO2019043208A1 (en) 2017-09-04 2019-03-07 F. Hoffmann-La Roche Ag DIHYDROQUINOLINONES
EP3897631A4 (en) 2018-12-20 2022-11-23 C4 Therapeutics, Inc. TARGETED PROTEIN BREAKDOWN

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3464985A (en) * 1967-08-18 1969-09-02 Bristol Myers Co 7 - (d - alpha - amino - (acetamidophenylacetamido))-cephalosporanic acids and derivatives thereof

Also Published As

Publication number Publication date
EP0011092B1 (en) 1982-06-23
JPS5533476A (en) 1980-03-08
DE2836613A1 (de) 1980-03-13
DE2963164D1 (en) 1982-08-12
DK349579A (da) 1980-02-23
EP0011092A1 (de) 1980-05-28
ATE1240T1 (de) 1982-07-15
FI792586A7 (fi) 1980-02-23
PT70078A (de) 1979-09-01
NO792590L (no) 1980-02-25

Similar Documents

Publication Publication Date Title
ES463126A1 (es) Procedimiento para preparar esteres de anilicos de acidos 4,5-dicloro-imidazol-1-carboxilicos.
IE872588L (en) Compounds
EP0011092B1 (en) Alpha-aminophenylacetic acid derivatives for use in the treatment of inflammations and novel alpha-aminophenylacetic acid derivatives
AU532411B2 (en) Phenyl piperazine derivatives
DE3060153D1 (en) Derivatives of substituted 2-benzoyl glycinanilides, their preparation and their use in anxiolytic medicaments
ES8402842A1 (es) "porcedimiento de preparar nuevos derivados de oxazinobenzotiazina-6,6-dioxido".
ES451136A1 (es) Procedimiento para la preparacion de nuevos compuestos hete-rociclicos conteniendo azufre.
ES445944A1 (es) Procedimiento de preparacion de derivados de 8-amino-teofi- lina.
DE3368609D1 (en) Carbacyclines, process for their preparation and their use as medicines
ES456048A1 (es) Procedimiento de preparacion de derivados de la piridoxina.
ES483298A1 (es) Un procedimiento para la preparacion de derivados de benzo- diacepina
GB1394563A (en) Process for preparing benzamides
ES467519A1 (es) Un procedimiento de preparacion de acidos furoil- o tenoil- naftiloxialcohilcarboxilicos.
ES485973A1 (es) Un procedimiento de preparacion de nuevos derivados de amino-3-sulfamido-6-(1h,3h)-quinazolin-dionas-2,4
ES483236A1 (es) Procedimiento de preparacion de derivados de pirazolidin- diona